Navigation Links
Heska Announces First Installation of New Blood Gas & Electrolyte Analyzer
Date:5/19/2010

LOVELAND, Colo., May 19 /PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq: HSKA) ("Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today the first installations of the Company's new VitalPath™ Blood Gas & Electrolyte Analyzer (the "VitalPath").

(Logo:  http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO)

Veterinary customers receiving these analyzers have invested in a major advancement to in-clinic diagnostics.  The VitalPath analyzer delivers accurate results in just 50 seconds for blood gases, electrolytes, and hematocrit, as well as 27 additional calculated parameters.  Requiring just under 70 microliters of sample, the VitalPath can be customized to suit the needs of any clinic.

"We are very pleased to offer the VitalPath analyzer as an essential part of the veterinary team's in-house laboratory," says Michael J. McGinley, President and Chief Operating Officer of Heska Corporation. "Our customers have the highest standards for companion animal care and in emergencies, they depend on fast, accurate results to make immediate treatment decisions.  We are proud to address this important need with the latest edition to our advanced line-up of diagnostic blood analyzers."

About Heska

Heska Corporation (Nasdaq: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products.  Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines.  The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.  For further information on Heska and its products, visit the company's website at www.heska.com.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results.  These statements are based on current expectations and are subject to a number of risks and uncertainties.  Investors should note that there is an inherent risk in using past results, including trends, to predict future outcomes.  In addition, factors that could affect the business and financial results of Heska generally include the following: uncertainties related to the performance of products as anticipated over time; uncertainties related to the timely and level of market acceptance of new products; risks related to Heska's reliance on third-party suppliers, which is significant; risks related to the commercialization of new products; competition; risks related to Heska's ability to maintain its listing on the NASDAQ Capital Market; risks related to Heska's ability to market and sell its products in an economically viable manner; uncertainties related to the impact of transfer restrictions on Heska's stock, which were approved by Heska stockholders at Heska's Annual Meeting of Stockholders on May 4, 2010; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Quarterly Report on Form 10-Q for the quarter ended March 31, 2010.


'/>"/>
SOURCE Heska Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Heska to Present at SunTrust Robinson Humphrey 1st Annual Veterinary Conference
2. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2009 Earnings Conference Call Webcast
3. Heska Announces Extension of Credit Agreement With Wells Fargo
4. Heska Announces Supply Agreement With Roche Diagnostics
5. Heska Announces Launch of New Website
6. Heska Announces Q309 Results
7. Winner Medical Group Inc. Announces Exercise of Over-Allotment Option Bringing Aggregate Net Proceeds of the Public Offering to $8.8 Million
8. Stryker Announces Resolution of Two FDA Warning Letters
9. Medical Product Outsourcing Magazine Announces the First Annual CardioTec Conference
10. Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation
11. China Sky One Medical Announces First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 18, 2017  ViewRay, Inc. (Nasdaq: ... first and only clinical MRI-guided radiation therapy system, announced ... of approximately $26.1 million through a private placement ... Management led the financing and was joined by ... LLC and Kearny Venture Partners, and an additional ...
(Date:1/19/2017)... , Jan. 18, 2017 The drug ... billion by 2021 from USD 1,179.20 billion in 2016, ... Increasing prevalence of chronic diseases, increasing demand for ... factors driving the growth of this market. Whereas, self-administration ... generic drugs offer significant growth opportunities for players operating ...
(Date:1/18/2017)... 18, 2017  Aprima Medical Software, a leading ... management (PM) and revenue cycle management (RCM) solutions ... a former reseller Healthcare Data Solutions (HDS) of ... Aprima will assume full support for HDS,s customers, ... practices across 15 states. Financial terms were not ...
Breaking Medicine Technology:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “The Angel”: ... the Lord has set out for each of his children. “The Angel” is the ... School of Music in New York City, and impassioned writer. , When asked of ...
(Date:1/20/2017)... ... 20, 2017 , ... D R Burton Healthcare Products LLC, ... featured in a study indicating superior performance against competitive products in secretion clearance. ... Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter ...
(Date:1/20/2017)... ... ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of prayers that reminds ... published author, Gene Gaapf, a retired truck driver, and a long-time writer, whose published ... high school and have many different titles,” Gaapf mentions about his different works. “I ...
(Date:1/19/2017)... (PRWEB) , ... January 20, 2017 , ... Today, the ... to participate in four of CMS’s Alternative Payment Models (APMs) in 2017. Clinicians who ... patients. APMs are an important part of the Administration’s effort to build a ...
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy ... enhancement of their 503A compounding pharmacy located in Ocala, Florida. , Meeting ... and patients throughout the United States for high-quality human anti-aging and wellness ...
Breaking Medicine News(10 mins):